SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of NAV, UROV, AKER, and EMIS Mergers
December 01, 2020 11:09 ET
|
Rigrodsky & Long, P.A.
WILMINGTON, Del., Dec. 01, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating: Navistar International Corporation (NYSE: NAV) regarding possible breaches of...
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of HDS, UROV, AKER, and TGC Mergers
November 19, 2020 18:11 ET
|
Rigrodsky & Long, P.A.
WILMINGTON, Del., Nov. 19, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating: HD Supply Holdings, Inc. (NASDAQ GS: HDS) regarding possible breaches of...
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Akers Biosciences, Inc. Merger
November 13, 2020 11:31 ET
|
Rigrodsky & Long, P.A.
WILMINGTON, Del., Nov. 13, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating Akers Biosciences, Inc. (“Akers”) (NASDAQ GS: AKER) regarding possible breaches of...
Akers Biosciences and Premas Biotech Announce SARS CoV-2 Positive Proof of Concept Results
August 27, 2020 09:00 ET
|
Akers Biosciences Inc.
Thorofare, New Jersey, Aug. 27, 2020 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a developer of rapid health information technologies, today announced with its...
Akers Biosciences Announces $6.8 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
August 11, 2020 08:00 ET
|
Akers Biosciences Inc.
Thorofare, New Jersey, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), today announced that it has entered into definitive agreements with several...
Akers Biosciences and Premas Biotech Announce Initiation of Animal Studies
July 07, 2020 09:00 ET
|
Akers Biosciences Inc.
Company intends to cease focus on screening and testing products business Thorofare, New Jersey, July 07, 2020 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a...
Akers Biosciences Closes $4.8 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
May 18, 2020 17:33 ET
|
Akers Biosciences Inc.
Thorofare, New Jersey, May 18, 2020 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a developer of rapid health information technologies, today announced the closing of...
Akers Biosciences Announces $4.8 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
May 14, 2020 13:00 ET
|
Akers Biosciences Inc.
Thorofare, New Jersey, May 14, 2020 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a developer of rapid health information technologies, today announced that it has...
Akers Biosciences and Premas Biotech Announce Successful Completion of Vaccine Prototype & Obtained First Images of VLP
May 14, 2020 09:33 ET
|
Akers Biosciences Inc.
Thorofare, New Jersey, May 14, 2020 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a developer of rapid health information technologies, today announced that Premas...
Akers Biosciences and Premas Biotech Announce Successful Expression of Coronavirus Antigens
April 08, 2020 09:25 ET
|
Akers Biosciences Inc.
Thorofare, New Jersey, April 08, 2020 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a developer of rapid health information technologies, today announced that its...